Quizartinib prolongs survival of newly diagnosed FLT3-ITD-mutated AML
Year: 2022
Type: conference-paper
DOI: 10.55788/d113a075
Authors: Harry Erba, Marten Dooper
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4285405614
